Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01878500
Other study ID # NA_00069579
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date December 31, 2020

Study information

Verified date November 2021
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the use of intraoperative stereotactic imaging of the pelvic floor musculature during closure of bladder exstrophy.


Description:

Much of the long-term success of classic bladder exstrophy closures depends on the initial closure. Several studies have demonstrated that a key to successful initial closure involves deep dissection of the pelvic floor so that the bladder can be placed in the most posterior and inferior position possible. Oftentimes, the need for repeat closure of the abdomen is required if the initial surgeon failed to properly dissect deep enough into the child's pelvic floor. Many surgeons are unfamiliar with the complex anatomy and are unable to verify that they have properly reached the true pelvic floor during this initial surgery. This often leads to failed closures, which result in poor continence rates later in life. The investigators are attempting to determine the safety and efficacy of the use the Brainlab, Inc. VisionVector® Cranial Image Guided Surgery System during closure of bladder exstrophy. The value of this research is two-fold. Firstly, the project will help us to verify if the investigators are indeed dissecting down to the proper plane required for successful initial closure of bladder exstrophy. Secondly, this project will help others with relatively less experience with bladder exstrophy to properly identify where they are anatomically during closure of exstrophy, thus yielding higher success rates and better patient care at other centers.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 7 Years
Eligibility Inclusion Criteria: 1. Age 0-7 years 2. Diagnosis of classic bladder exstrophy 3. Scheduled to undergo bladder exstrophy closure by the principal investigator at Johns Hopkins Hospital's Broadway campus. 4. All eligible participants will be children whose parents or legally authorized representatives have already agreed and are being scheduled for osteotomy and bladder exstrophy closure as determined by their pediatric urologist. 5. Parent or legally authorized representative who is, in the opinion of the investigator, reliable and willing to make themselves and patient available for the duration of the study. 6. Parent or legally authorized representative is able to complete and sign the informed consent document. 7. Patient judged by the investigator to have bladders of sufficient size and elasticity to be suitable for immediate closure as evidenced by the PI's assessment of the patient's bladder template [16]. 8. Patient with cardiopulmonary function sufficient to tolerate general anesthesia as evidenced by the pediatrician's and anesthesiologists assessment of the patient's overall cardio-pulmonary status. 9. Patients requiring ferromagnetic metal objects such as a metal pace maker during the OR procedure. Exclusion Criteria: 1. Lack or withdrawal of consent for primary operative procedure. 2. Parent or legally authorized representative who is, in the opinion of the investigator, not reliable or unwilling to make themselves and patient available for the duration of the study. 3. Parent or legally authorized representative who is unable to understand, complete and/or sign the informed consent document. Non-English speaking parents will automatically be excluded if they are unable to read and understand the consent form. 4. Patient who will not undergo osteotomy prior to closure for any reason

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intraoperative stereotactic imaging with VectorVision
Surgeon will use intraoperative stereotactic imaging with VectorVision® Cranial Guided Image System by Brainlab Inc. to assist in bladder exstrophy closure. Prior to the operation a team consisting of pediatric urologist, pediatric radiologists, and a VectorVision rep will use pre-operative MRI to map out specific bony and muscular structures of the pelvic floor. Doing so will allow the pediatric urologist to use these markers intraoperatively to help guide his closure and also allow for future surgeons who use this technology to understand the correct planes to develop for the same surgery.

Locations

Country Name City State
United States Brady Urological Institute. Johns Hopkins University Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Success or Failure of Exstrophy Closure A failed bladder closure was defined as bladder prolapse, dehiscence, outlet obstruction, persistent vesicourethral fistula, or a combination of these, or a complication that required repeat closure. 2 years
Secondary Urinary Continence Continence rates as determined by total dry time during the day, number of incontinent episodes, and need for dry pads. 2 years
Secondary Operative Time Time (measured in minutes) of operation. Intraoperatively
Secondary Length of Hospital Stay Length of hospital stay (in days) for each participant. Up to 2 months
Secondary Peri-operative Complications as Assessed by the Total Number of Transfusions Peri-operative complications were those encountered immediately before, during, or immediately following the case, primarily regarding need for blood transfusions. Though these are not complications (and deemed necessary/inherent to the operation), they are tracked closely as an outcome measure. Intraoperatively
Secondary Subjective Improved Identification of the Pelvic Floor Anatomy During Bladder Exstrophy Closure as Reported by the Surgeon Surgeon's were surveyed post-operatively on whether the intervention improved identification of pelvic floor anatomy.
Measure: Binary, 'Yes' and 'No'
Intraoperatively
Secondary Total Number of Post-operative Complications Post-operative complications were graded on the Clavien-Dindo Classification System. The Clavien-Dindo System is a standardized classification for reporting and registering complications. It grades the severity of a complication based on the therapy required to treat the complication. It is a tiered system with subdivided categories as follows:
Grade I and II are considered minor, Grade III is considered moderate and Grades IV and V are severe complications.
2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03698721 - Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
Not yet recruiting NCT04580186 - Outcome Of Classic Bladder Exstrophy Repair, Assiut University Experience
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Terminated NCT01011777 - Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence Phase 1
Recruiting NCT03061084 - Prospective Cohort of Transitional Urology Patients
Completed NCT00863070 - Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy N/A
Completed NCT05690594 - Long-term Outcomes of Patients Treated for Bladder Exstrophy by Questionnaires.
Recruiting NCT04935918 - EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENCE THERAPY BALLOONS IN BLADDER EXSTROPHY AND INCONTINENT EPISPADIAS PATIENTS N/A